Royalty Pharma plc (RPRX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Royalty Pharma plc, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$64.82
−0.70% today
Market cap
$37.5B
Overall quality
—
Kronos AI 30-day
−14.8%
0 of 8 simulated paths end higher
Royalty Pharma plc (RPRX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $37.5B. It trades at $64.82, down 0.70% today. 7 analysts' average target of $66.00 implies +1.8% from today's price. Kronos AI's 30-day forecast is −14.8% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $66.00 |
| Low – high | $62.00 – $70.00 |
| Analysts | 7 |
| Upside to average | +1.8% |
Kronos AI 30-day forecast
| Expected close | $55.58 (−14.8%) |
| Likely range | −16.7% … −13.7% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.